ENG/中
老虎证券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Inhibrx Biosciences, Inc.
15.86
0.0000
成交量：
- -
成交额：
1,097.66万
市值：
2.26亿
市盈率：
- -
高：
15.86
开：
15.86
低：
15.86
收：
15.86
52周最高：
15.86
52周最低：
15.86
股本：
1,424.00万
流通股本：
1,424.00万
量比：
- -
换手率：
- -
股息：
- -
股息率：
- -
净资产收益率：
--
总资产收益率：
--
市净率：
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
Inhibrx Biosciences, Inc.盘中异动 下午盘股价大涨5.39%
市场透视
·
2025/08/21
Inhibrx Biosciences, Inc.盘中异动 下午盘股价大跌5.46%报22.94美元
市场透视
·
2025/07/31
Inhibrx Biosciences, Inc.盘中异动 临近午盘快速下挫5.26%
市场透视
·
2025/07/29
Inhibrx Biosciences, Inc.盘中异动 股价大涨5.11%
市场透视
·
2025/07/28
Inhibrx Biosciences, Inc.盘中异动 早盘股价大跌5.20%
市场透视
·
2025/07/25
Inhibrx Biosciences, Inc.盘中异动 下午盘急速下挫5.69%
市场透视
·
2025/07/22
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/INXB/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"INXB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INXB\",,,,,undefined,":{"symbol":"INXB","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences, Inc.","latestPrice":15.86,"timestamp":1717099200000,"preClose":15.86,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":14240000,"shares":14240000,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"05-30 16:00:00 EDT","open":15.86,"high":15.86,"low":15.86,"amount":10976590.3275,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"INBX","executeDate":"2024-05-31"},"adr":0,"exchange":"NASDAQ","adjPreClose":15.86,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INXB\",,,,,undefined,":{"symbol":"INXB","floatShares":14240000,"roa":"--","roe":"--","lyrEps":0,"shares":14240000,"dividePrice":0,"high":15.86,"amplitude":0,"preClose":15.86,"low":15.86,"week52Low":15.86,"pbRate":"--","week52High":15.86,"institutionHeld":0,"latestPrice":15.86,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":15.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INXB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-31","symbol":"INXB","oldSymbol":"INXB","defaultRemindTime":1717162200000,"newSymbol":"INBX","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1717128000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INXB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INXB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1723608000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INXB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561486216","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561486216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561486216?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 03:13","pubTimestamp":1755717201,"startTime":"0","endTime":"0","summary":"北京时间2025年08月21日03时13分，Inhibrx Biosciences, Inc.股票出现异动，股价快速拉升5.39%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Radiopharm Theranostics Limited涨幅较大，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5449.39%、2844.17%、466.86%，振幅较大的相关个股有Tharimmune, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Windtree Therapeutics, Inc.，振幅分别为192.31%、100.00%、81.79%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082103132194f0636d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082103132194f0636d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","INXB","BK4139"],"gpt_icon":0},{"id":"2555290590","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘股价大跌5.46%报22.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555290590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555290590?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 03:22","pubTimestamp":1753903353,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时22分，Inhibrx Biosciences, Inc.股票出现波动，股价急速下跌5.46%。截至发稿，该股报22.94美元/股，成交量5.0501万股，换手率0.35%，振幅7.01%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032233a46c06ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032233a46c06ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INBX","INXB"],"gpt_icon":0},{"id":"2555006841","title":"Inhibrx Biosciences, Inc.盘中异动 临近午盘快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555006841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555006841?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 23:55","pubTimestamp":1753804502,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时55分，Inhibrx Biosciences, Inc.股票出现异动，股价急速跳水5.26%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292355039725bcb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292355039725bcb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INXB","INBX"],"gpt_icon":0},{"id":"2554777534","title":"Inhibrx Biosciences, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554777534?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 21:56","pubTimestamp":1753710974,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时56分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅拉升5.11%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215614972356a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215614972356a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139","INXB"],"gpt_icon":0},{"id":"2554793983","title":"Inhibrx Biosciences, Inc.盘中异动 早盘股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554793983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554793983?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 21:40","pubTimestamp":1753450855,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日21时40分，Inhibrx Biosciences, Inc.股票出现波动，股价急速下跌5.20%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725214055a4637d2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725214055a4637d2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INXB","INBX"],"gpt_icon":0},{"id":"2553406354","title":"Inhibrx Biosciences, Inc.盘中异动 下午盘急速下挫5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553406354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553406354?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 02:01","pubTimestamp":1753120879,"startTime":"0","endTime":"0","summary":"北京时间2025年07月22日02时01分，Inhibrx Biosciences, Inc.股票出现波动，股价急速跳水5.69%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722020119a45a460b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722020119a45a460b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INXB","INBX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}